Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Metastatic Castrate Resistant Prostate Cancer × masitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Pruritus 2 Piebaldism 2 Pancreatic Neoplasms 2 Neoplasm Metastasis 2 Mastocytosis, Systemic 2 Mastocytosis 2 Gastrointestinal Stromal Tumors 2 Blushing 2 Recurrence 1 Multiple Myeloma 1 Metastatic Castrate Resistant Prostate Cancer 1 Melanoma 1 Gastro-Intestinal Stromal Tumour 1 Colorectal Neoplasms 1

Interventions

masitinib 1 Prednisone 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03761225 2023-09-29

Masitinib Plus Docetaxel in Metastatic Castration-resistant Prostate Cancer

AB Science

Phase 3 Completed

Metastatic Castrate Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡